These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 28110464)

  • 1. Alexithymia in people with subjective cognitive decline, mild cognitive impairment, and mild Alzheimer's disease.
    Yuruyen M; Akcan FE; Batun GC; Gultekin G; Toprak M; Yavuzer H; Emul M
    Aging Clin Exp Res; 2017 Dec; 29(6):1105-1111. PubMed ID: 28110464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Initial Study of Alexithymia and Its Relationship With Cognitive Abilities Among Mild Cognitive Impairment, Mild Alzheimer's Disease, and Healthy Volunteers.
    Smirni D; Beadle JN; Paradiso S
    J Nerv Ment Dis; 2018 Aug; 206(8):628-636. PubMed ID: 30020208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Awareness of memory deficits in subjective cognitive decline, mild cognitive impairment, Alzheimer's disease and Parkinson's disease.
    Lehrner J; Kogler S; Lamm C; Moser D; Klug S; Pusswald G; Dal-Bianco P; Pirker W; Auff E
    Int Psychogeriatr; 2015 Mar; 27(3):357-66. PubMed ID: 25382659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semantic memory and depressive symptoms in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer's disease.
    Lehrner J; Coutinho G; Mattos P; Moser D; Pflüger M; Gleiss A; Auff E; Dal-Bianco P; Pusswald G; Stögmann E
    Int Psychogeriatr; 2017 Jul; 29(7):1123-1135. PubMed ID: 28372598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH; Park H; Sohn SW; Kim S; Park KW
    Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memory complaints in subjective cognitive impairment, amnestic mild cognitive impairment and mild Alzheimer's disease.
    Ryu SY; Lee SB; Kim TW; Lee TJ
    Acta Neurol Belg; 2016 Dec; 116(4):535-541. PubMed ID: 26861053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden.
    Sheikh F; Ismail Z; Mortby ME; Barber P; Cieslak A; Fischer K; Granger R; Hogan DB; Mackie A; Maxwell CJ; Menon B; Mueller P; Patry D; Pearson D; Quickfall J; Sajobi T; Tse E; Wang M; Smith EE;
    Int Psychogeriatr; 2018 Feb; 30(2):233-244. PubMed ID: 28879833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.
    Van der Mussele S; Bekelaar K; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):947-58. PubMed ID: 23255479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.
    Park SJ; Lee JE; Lee KS; Kim JS
    Neurol Sci; 2018 Mar; 39(3):557-564. PubMed ID: 29383614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internal Consistency Over Time of Subjective Cognitive Decline: Drawing Preclinical Alzheimer's Disease Trajectories.
    Ávila-Villanueva M; Maestú F; Fernández-Blázquez MA
    J Alzheimers Dis; 2018; 66(1):173-183. PubMed ID: 30248053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer's Disease.
    Lim YY; Kong J; Maruff P; Jaeger J; Huang E; Ratti E
    J Prev Alzheimers Dis; 2022; 9(1):178-183. PubMed ID: 35098989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subjective Cognitive Complaints: Comparing the Relation between Self-Reported Versus Informant-Reported Subjective Cognitive Complaints and Cognitive Performances in Cognitively Unimpaired, Mild Cognitive Impairment and Populations with Dementia.
    Peng SW; Wang CY; Lin SY; Lee YL; Lin YC; Lin YJ; Wang PN
    J Prev Alzheimers Dis; 2023; 10(3):562-570. PubMed ID: 37357298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic white matter pathways along the Alzheimer's disease continuum.
    Nemy M; Dyrba M; Brosseron F; Buerger K; Dechent P; Dobisch L; Ewers M; Fliessbach K; Glanz W; Goerss D; Heneka MT; Hetzer S; Incesoy EI; Janowitz D; Kilimann I; Laske C; Maier F; Munk MH; Perneczky R; Peters O; Preis L; Priller J; Rauchmann BS; Röske S; Roy N; Scheffler K; Schneider A; Schott BH; Spottke A; Spruth EJ; Wagner M; Wiltfang J; Yakupov R; Eriksdotter M; Westman E; Stepankova O; Vyslouzilova L; Düzel E; Jessen F; Teipel SJ; Ferreira D
    Brain; 2023 May; 146(5):2075-2088. PubMed ID: 36288546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial navigation measured by the Floor Maze Test in patients with subjective cognitive impairment, mild cognitive impairment, and mild Alzheimer's disease.
    Tangen GG; Engedal K; Bergland A; Moger TA; Hansson O; Mengshoel AM
    Int Psychogeriatr; 2015 Aug; 27(8):1401-9. PubMed ID: 25644091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of subjective memory complaint and depressive symptoms with objective cognitive functions in prodromal Alzheimer's disease including pre-mild cognitive impairment.
    Seo EH; Kim H; Choi KY; Lee KH; Choo IH
    J Affect Disord; 2017 Aug; 217():24-28. PubMed ID: 28380342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.